Person

Patrycja Nowak-Sliwinska

This person is no longer with EPFL

Related publications (53)

About
Privacy
Disclaimer

Graph Chatbot

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Patrycja Nowak-Sliwinska

Graph Chatbot

Chat with Graph Search

Recent Considerations in the Application of RAPTA-C for Cancer Treatment and Perspectives for Its Combination with Immunotherapies

Towards Light-Activated Ruthenium-Arene (RAPTA-Type) Prodrug Candidates

Consensus guidelines for the use and interpretation of angiogenesis assays

Development of an Efficient Dual-Action GST-Inhibiting Anticancer Platinum(IV) Prodrug

Combination of ruthenium(II)-arene complex [Ru(eta(6)-p-cymene)Cl-2(pta)] (RAPTA-C) and the epidermal growth factor receptor inhibitor erlotinib results in efficient angiostatic and antitumor activity

Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment

Drug Combination for Treatment of Proliferative Diseases

Current Trends in Multidrug Optimization: An Alley of Future Successful Treatment of Complex Disorders

Optimization of drug combinations using Feedback System Control

Chlorambucil conjugates of dinuclear p-cymene ruthenium trithiolato complexes: synthesis, characterization and cytotoxicity study in vitro and in vivo